Keyphrases
Tumor
82%
Confidence Interval
59%
Neurofibromatosis Type 1 (NF-1)
43%
Breast Cancer
41%
Relative Risk
33%
Breast Cancer Risk
30%
Neurofibromatosis Type I
28%
In Cancer
26%
Nurses' Health Study
23%
T Cells
22%
Hematopoietic Stem Cells
21%
Colorectal Cancer
18%
Tumor Cells
18%
Glioblastoma
18%
Gene Expression
18%
Body Mass Index
17%
Overall Survival
17%
Postmenopausal Women
17%
Prostate Cancer
16%
Radiation Therapy
16%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
16%
Acute Myeloid Leukemia
15%
Risk Factors
15%
Odds Ratio
15%
Meta-analysis
15%
Macrophages
15%
United States
14%
Hazard Ratio
14%
Chemotherapy
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Clinical Trials
14%
Bone Marrow
14%
Mouse Model
13%
Physical Activity
13%
Interferon-α (IFN-α)
13%
Apoptosis
13%
Obesity
13%
Glioma
12%
Natural Killer Cells
12%
Cancer Cells
12%
Osteoclast
11%
Tumor Growth
11%
Phosphorylation
11%
Transcription Factor
11%
Ovarian Cancer
11%
Pancreatic Cancer
10%
Tumor Microenvironment
10%
Overexpression
10%
Tumor Suppressor
10%
Multiple Myeloma
10%
Clinical Outcomes
9%
Lung Cancer
9%
Dendritic Cells
9%
Melanoma
9%
Brain Tumor
9%
Coronary Artery Disease
9%
Immune Response
9%
Tumorigenesis
9%
Colorectal Cancer Risk
9%
Estrogen
9%
Optic Pathway Glioma
9%
Prospective Cohort Study
9%
Signaling Pathway
9%
Astrocytes
9%
Granulocyte Colony-stimulating Factor (G-CSF)
9%
NF-B
9%
Inflammation
9%
Malignancy
8%
High Risk
8%
Ionizing Radiation
8%
Cervical Cancer
8%
Metastasis
8%
Leukemia
8%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
8%
Cell Proliferation
8%
Diabetes
8%
Bladder Cancer
7%
Human Cancer
7%
Virus
7%
Cancer Types
7%
Oncogene
7%
Cancer Patients
7%
Optical Coherence Tomography
7%
Radiotherapy
7%
Endothelial Cells
7%
Catenin
7%
Cell Death
7%
DNA Damage
7%
CD8+ T Cells
7%
Tumor Progression
7%
Colon Cancer
7%
Neurofibromin
7%
Systematic Meta-analysis
7%
Tumor Necrosis Factor-α
7%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Integrin
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Breast Cancer Patients
7%
Myelodysplastic Syndrome
7%
Magnetic Resonance Imaging
7%
Medicine and Dentistry
Neoplasm
100%
Malignant Neoplasm
68%
Breast Cancer
67%
Disease
40%
Neurofibromatosis Type I
29%
Radiation Therapy
25%
Ganglioglioma
20%
Colorectal Carcinoma
20%
Metastatic Carcinoma
18%
Chemotherapy
17%
Cancer Risk
17%
Overall Survival
16%
Prostate Cancer
16%
T Cell
15%
Prospective Study
14%
Clinical Trial
14%
Nurse
13%
Tumor Progression
13%
Biological Marker
13%
Recurrent Disease
13%
Cancer Cell
13%
Glioblastoma
12%
Ovarian Cancer
12%
Surgery
12%
Tumor Cell
12%
Hematopoietic Cell
12%
Magnetic Resonance Imaging
11%
In Vitro
11%
Cancer
11%
Systematic Review
10%
Hazard Ratio
10%
Meta-Analysis
10%
Body Mass Index
10%
Odds Ratio
9%
Melanoma
9%
Carcinogenesis
9%
Lung Cancer
9%
Acute Myeloid Leukemia
9%
Programmed Cell Death
8%
Diabetes
8%
Gene Expression
8%
Cancer Therapy
8%
Cervical Cancer
8%
Positron Emission Tomography
8%
Immunotherapy
8%
Macrophage
8%
Intracranial Tumor
8%
Alcohol Consumption
8%
Diagnosis
8%
Pancreas Cancer
8%
Receptor
8%
Protein P53
8%
Immunity
7%
Hematopoiesis
7%
Connective Tissue Cancer
7%
Multiple Myeloma
7%
Optical Coherence Tomography
7%
Targeted Therapy
7%
Signal Transduction
7%
Physical Activity
7%
Osteoclast
7%
Tumor Microenvironment
7%
Postmenopause
6%
Progression Free Survival
6%
Leukemia
6%
Cohort Analysis
6%
Pediatrics
6%
Xenograft
6%
Bladder Cancer
6%
Oncology
6%
Infection
6%
Stem Cell
6%
Immunohistochemistry
6%
Biopsy Technique
6%
Adolescence
6%
Endothelial Cell
6%
Lymph Node
6%
Non Small Cell Lung Cancer
5%
Osteolysis
5%
Pancreas Adenocarcinoma
5%
Isotopes of Calcium
5%
Messenger RNA
5%
Hormone Therapy
5%
Head and Neck Cancer
5%
Nanoparticle
5%
Health Care Cost
5%
Malignant Peripheral Nerve Sheath Tumor
5%
Cancer Mortality
5%
Prospective Cohort Study
5%
Gene Mutation
5%
Estrogen Receptor
5%
Quality of Life
5%
Ischemic Heart Disease
5%
Colon Carcinoma
5%
Uterine Cancer
5%
Soft Tissue Sarcoma
5%
Adverse Event
5%